Life Sciences

The biomanufacturing park being built at the site of the former Worcester State Hospital will now be known as The Reactory, according to landowner Worcester Business Development Corp. 

Another Marlborough medical device manufacturer is partnering with a celebrity to help market a new device intended to tone and strengthen and tone the abs, arms, and buttocks. 

Marlborough insulin delivery company CeQur has named medtech veteran Bradley Paddock as its new CEO. 

Marlborough biotech manufacturer ReWalk Robotics’ stock skyrocketed Wednesday, rising more than 180% after the company announced FDA clearance of one of ReWalk's main products.

The Massachusetts Life Sciences Center is launching a new program for investments of up to $1 million go to promising life science startups in regions outside of the Boston biotech cluster. 

Jon Weaver took over as president and CEO of Worcester biotech incubator Massachusetts Biomedical Initiatives after Kevin O’Sullivan retired at the end of 2018 after two decades leading the agency.

Marlborough cardiac device firm CardioFocus has completed a $55-million round of financing intended to accelerate the commercial introduction of a new generation of its flagship product. 

The U.S. Food and Drug Administration has approved the first two tests to detect certain sexually transmitted infections outside of the genitals, and one of those tests belongs to Marlborough medical device maker Hologic. 

Boston Scientific has begun a trial to compare the safety and effectiveness of the next generation of one of its flagship atrial fibrillation devices.

Hologic CEO Steve MacMillan was the fifth-highest-paid CEO among the country's largest public companies, according to the latest annual analysis by The Wall Street Journal.